the core of our corporate values
On August 23, Zylox-Tonbridge (2190.HK) announced that Tonbridge GyclineTM Microcatheter, a product independently developed by Zhuhai Ton-bridge Medical Technology Co., Ltd. (hereinafter referred to a...
Zylox-Tonbridge (2190.HK) recently announced that it has respectively set up an office in Beijing and a R&D center in Shanghai to attract more outstanding industry talents and promote the rapid an...
On July 12, 2021, ZYLOX-TONBRIDGE (2190.HK) announced that the Company has successfully completed enrollment in the PEVENSEY study. The PEVENSEY study is a prospective multicenter randomized controlle...
Zylox-Tonbridge is launching the CYLONE™ Aspiration Catheter in the global market. After introducing the Thrombite™ Clot Retriever Device last year, Zylox-Tonbridge brings again a new option for pat...
On 27th April 2021, the opening ceremony of ZYLOX-TONBRIDGE Industrial Park was held grandly.The park was completed and put into use on April 10th, 2021, covering an area of nearly 23 acres. The park ...
In March 2021, Zhuhai TonBridge Medical Technology Co., Ltd. was once again selected as a technology-based SMEs in Guangdong successfully. So far, TonBridge Medical has been in the list technology-bas...